Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

Jacoline Bromberg, S Issa, Katerina Bakunina, MC Minnema, T Seute, M Durian, G Cull, HC Schouten, WBC Stevens, JM Zijlstra, JW Baars, M Nijland, KD Mason, A Beeker, Martin van den Bent, M Beijert, M Gonzales, D Jong, Jeanette Doorduijn

Research output: Contribution to journalArticleAcademicpeer-review

144 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)216-228
Number of pages13
JournalLancet Oncology
Issue number2
Publication statusPublished - 2019

Research programs

  • EMC MM-02-41-03

Cite this